D313Y variant in two related end-stage renal disease patients ¿ Pathogenic or not yet? Rita Vicente; Iolanda Santos; Miguel Coimbra; Joana Santos; Ricardo Santos; Manuel Amoedo; Carlos Pires;

Is just enzyme replacement therapy enough for Fabry disease treatment? Have we missed a trick? Hakan Ozer; Ismail Baloglu; Ali Topkac; Yasin Ozturk; Fethi Yonet; Furkan Dagl¿; ¿brahim Kilinc; Kultigin Turkmen;

Fabry disease as a trigger of immune-mediated glomerular disease: Clinical hypotheses and literature review Javier Martínez de Victoria Carazo; Haylen Marin; Francisco Javier De la Hera Fernández; Carlos Mañero Rodríguez; César Ramírez Tortosa; José Luís Callejas Rubio;